|Day Low/High||9.80 / 10.00|
|52 Wk Low/High||3.26 / 7.97|
AxoGen to host expert panel discussion and interactive session on new nerve repair technologies
In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.92, changing hands for $8.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Expanded Nerve Product Portfolio and Other Business Updates to be Discussed Today at AxoGen's Analyst & Investor Event
In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.25, changing hands for $8.55/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Record revenues of $11.2 million, continued growth in accounts, and increased presence of nerve repair at key medical meetings
New Agreement Will Replace Existing $25 million Term Loan and Revenue Interest Royalty Agreement, and Reduce Annual Interest Costs by at Least $1.5 Million
Investors considering a purchase of AxoGen Inc stock, but cautious about paying the going market price of $8.77/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2017 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.
Former Covidien Senior Executive Brings More Than 30 Years of Experience to AxoGen Board
Expanded Role of Nerve Awareness and Repair in 30 Separate Conference Sessions and Presentations
Increasing Awareness of Nerve Injury and Repair in Multiple Conference Presentations
Second Quarter Revenues of $10.4M grew 62% over prior year
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
These under-$10 stocks are within range of triggering breakout trades.
TheStreet highlights 3 stocks that pushed the Health Services industry